{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:15:11Z","timestamp":1791353711593,"version":"4.3.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.jbspin.2006.02.004","type":"journal-article","created":{"date-parts":[[2006,5,7]],"date-time":"2006-05-07T11:12:54Z","timestamp":1147000374000},"page":"374-378","source":"Crossref","is-referenced-by-count":19,"title":["Drug combination strategies for\u00a0osteoporosis"],"prefix":"10.1016","volume":"73","author":[{"given":"Maurice","family":"Audran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2006.02.004_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2006.02.004_bib2","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jnci\/djh319","article-title":"Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene","volume":"96","author":"Martino","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jbspin.2006.02.004_bib3","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1210\/jc.87.8.3609","article-title":"Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial","volume":"87","author":"Delmas","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbspin.2006.02.004_bib4","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years\u2019 experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2006.02.004_bib5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00223-004-0286-7","article-title":"Seven years of treatment with risedronate in women with postmenopausal osteoporosis","volume":"75","author":"Mellstrom","year":"2004","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.jbspin.2006.02.004_bib6","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"349","author":"Black","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2006.02.004_bib7","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","article-title":"The effects of parathyroid hormone, alendronate, or both in men with osteoporosis","volume":"349","author":"Finkelstein","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2006.02.004_bib8","unstructured":"Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled"},{"key":"10.1016\/j.jbspin.2006.02.004_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0002-9343(98)00029-1","article-title":"A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis","volume":"104","author":"Wimalawansa","year":"1998","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jbspin.2006.02.004_bib10","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1210\/jc.84.9.3076","article-title":"Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized controlled clinical trial","volume":"84","author":"Lindsay","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbspin.2006.02.004_bib11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1210\/jc.85.2.720","article-title":"Alendronate and estrogen effects in postmenopausal women with low bone density","volume":"85","author":"Bone","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbspin.2006.02.004_bib12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.7326\/0003-4819-137-11-200212030-00008","article-title":"Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double blind, placebo-controlled trial","volume":"137","author":"Greenspan","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jbspin.2006.02.004_bib13","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1210\/jc.86.5.1890","article-title":"Effect of combined risedronate and hormone replacement therapies on bone mineral density in post-menopausal women","volume":"86","author":"Harris","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbspin.2006.02.004_bib14","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1210\/jc.87.3.985","article-title":"Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis","volume":"87","author":"Johnell","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbspin.2006.02.004_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","article-title":"Intermittent cyclical etidronate treatment of postmenopausal osteoporosis","volume":"323","author":"Watts","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2006.02.004_bib16","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2006.02.004_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jbspin.2003.08.002","article-title":"Efficacy data on teriparatide (parathyroid hormone) in patients with postmenopausal osteoporosis","volume":"70","author":"Debiais","year":"2003","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2006.02.004_bib18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1359\/jbmr.040117","article-title":"Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate","volume":"19","author":"Ettinger","year":"2004","journal-title":"J. Bone Miner. Res."},{"issue":"Suppl 2","key":"10.1016\/j.jbspin.2006.02.004_bib19","first-page":"S174","article-title":"Response of BMD and back pain to 12 months of teriparatide (rhPTH 1\u201334) in patients with and without prior antiresorptive treatment: one-year-interim results from the Eurofors study","author":"Minne","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jbspin.2006.02.004_bib20","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1001\/archinte.164.18.2024","article-title":"Sustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis","volume":"164","author":"Lindsay","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jbspin.2006.02.004_bib21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1359\/jbmr.2001.16.5.925","article-title":"Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal","volume":"16","author":"Cosman","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jbspin.2006.02.004_bib22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1210\/jc.82.2.620","article-title":"A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis","volume":"82","author":"Hodsman","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbspin.2006.02.004_bib23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1056\/NEJMoa050157","article-title":"Daily and cyclic parathyroid hormone in women receiving alendronate","volume":"353","author":"Cosman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2006.02.004_bib24","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1210\/jc.85.6.2129","article-title":"Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate","volume":"85","author":"Rittmaster","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jbspin.2006.02.004_bib25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa050336","article-title":"One year of alendronate after one year of parathyroid hormone (1\u201384) for osteoporosis","volume":"353","author":"Black","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 2","key":"10.1016\/j.jbspin.2006.02.004_bib26","first-page":"S54","article-title":"Effects of discontinuation of teriparatide treatment on cortical bone in postmenopausal women with osteoporosis","volume":"18","author":"Bogado","year":"2003","journal-title":"J. Bone Miner. Res."}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X06001357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X06001357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T18:29:19Z","timestamp":1547663359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X06001357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S1297319X06001357"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2006.02.004","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}